tiprankstipranks
Trending News
More News >
Braxia Scientific (BRAXF)
OTHER OTC:BRAXF

Braxia Scientific (BRAXF) Price & Analysis

Compare
109 Followers

BRAXF Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

<0.01%100.00%
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors

BRAXF FAQ

What was Braxia Scientific’s price range in the past 12 months?
Currently, no data Available
What is Braxia Scientific’s market cap?
Braxia Scientific’s market cap is $1.03M.
    When is Braxia Scientific’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Braxia Scientific’s earnings last quarter?
    Currently, no data Available
    Is Braxia Scientific overvalued?
    According to Wall Street analysts Braxia Scientific’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Braxia Scientific pay dividends?
      Braxia Scientific does not currently pay dividends.
      What is Braxia Scientific’s EPS estimate?
      Braxia Scientific’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Braxia Scientific have?
      Braxia Scientific has 283,280,360 shares outstanding.
        What happened to Braxia Scientific’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Braxia Scientific?
        Currently, no hedge funds are holding shares in BRAXF

        Company Description

        Braxia Scientific

        Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery methods; and development and acquisition of derivatives of ketamine and psilocybin, as well as other psychedelic products from its IP development platform. Braxia Scientific Corp. is headquartered in Toronto, Ontario.
        Similar Stocks
        Company
        Price & Change
        Follow
        Entheon Biomedical
        HAVN Life Sciences
        Lexston Life Sciences Corp.
        Doseology Sciences
        Lophos Holdings, Inc.
        Popular Stocks
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis